DNA encapsidation as a target for anti-herpesvirus drug therapy.
about
Agents and strategies in development for improved management of herpes simplex virus infection and disease.Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.The effect of N- or C-terminal alterations of the connector of bacteriophage phi29 DNA packaging motor on procapsid assembly, pRNA binding, and DNA packagingThe varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.Development of new antivirals for herpesviruses.Non-axial view of the varicella-zoster virus portal protein reveals conserved crown, wing and clip architecture.Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptaseOverview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy.The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54.Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.New insights into viral structure and virus-cell interactions through proteomics.Viral nanomotors for packaging of dsDNA and dsRNAPhosphorylation of Bovine Herpesvirus 1 VP8 Plays a Role in Viral DNA Encapsidation and Is Essential for Its Cytoplasmic Localization and Optimal Virion Incorporation.The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits.Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins.Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1.
P2860
Q30350341-98DFF6C6-AE50-4762-BDF4-2838865973E4Q33331830-3A7CB7B9-BFC5-4565-8DBD-45CD1ABB9C20Q33795162-F874DBC9-F2B9-4B03-80FF-8247FF60BA6DQ33900399-CBA6A69C-4AAA-4E33-9FFD-ADCF85E21E40Q35023298-19769889-46DF-429A-8205-B7B24955F1E3Q35669533-9DF13E66-6FA2-4C78-A363-9CE0B8912994Q35770254-7286EBE0-30CB-4E39-9E28-CA83F93CF7B1Q35828340-34521EDA-980D-44DF-AB0F-0409B2400B2BQ35917421-6469B5EE-093D-48F8-B00A-2AF1BF9030D5Q35992020-640CDCE6-AC56-4DFD-9E39-03D8071B4F8EQ36080899-39EDBB3F-6C27-4564-A46E-082EAD858A62Q36227964-CDB719A4-8B25-4996-998E-53B61D4B9829Q36628654-D520C26E-8268-4DEA-931E-636ECBFE550DQ36811884-94E8D4A4-F579-47E1-A835-7575D58AF936Q37158547-8D18FCA3-DEF7-47A2-98B4-2C7FB903095FQ37330959-2E7CCA77-C63C-4BB0-9B3C-56AEEB4E8DE8Q42063435-9FDF7A63-6B5C-482E-9255-B281D8C4AC78
P2860
DNA encapsidation as a target for anti-herpesvirus drug therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@ast
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@en
type
label
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@ast
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@en
prefLabel
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@ast
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@en
P1433
P1476
DNA encapsidation as a target for anti-herpesvirus drug therapy.
@en
P2093
Marja van Zeijl
Robert J Visalli
P356
10.1016/S0166-3542(03)00108-6
P577
2003-07-01T00:00:00Z